Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort study.


Journal

BMC infectious diseases
ISSN: 1471-2334
Titre abrégé: BMC Infect Dis
Pays: England
ID NLM: 100968551

Informations de publication

Date de publication:
13 Jun 2022
Historique:
received: 30 08 2021
accepted: 25 04 2022
entrez: 13 6 2022
pubmed: 14 6 2022
medline: 16 6 2022
Statut: epublish

Résumé

The impact of the variant of concern (VOC) Alpha on the severity of COVID-19 has been debated. We report our analysis in France. We conducted an exposed/unexposed cohort study with retrospective data collection, comparing patients infected by VOC Alpha to contemporaneous patients infected by historical lineages. Participants were matched on age (± 2.5 years), sex and region of hospitalization. The primary endpoint was the proportion of hospitalized participants with severe COVID-19, defined as a WHO-scale > 5 or by the need of a non-rebreather mask, occurring up to day 29 after admission. We used a logistic regression model stratified on each matched pair and accounting for factors known to be associated with the severity of the disease. We included 650 pairs of patients hospitalized between Jan 1, 2021, and Feb 28, 2021, in 47 hospitals. Median age was 70 years and 61.3% of participants were male. The proportion of participants with comorbidities was high in both groups (85.0% vs 90%, p = 0.004). Infection by VOC Alpha was associated with a higher odds of severe COVID-19 (41.7% vs 38.5%-aOR = 1.33 95% CI [1.03-1.72]). Infection by the VOC Alpha was associated with a higher odds of severe COVID-19.

Sections du résumé

BACKGROUND BACKGROUND
The impact of the variant of concern (VOC) Alpha on the severity of COVID-19 has been debated. We report our analysis in France.
METHODS METHODS
We conducted an exposed/unexposed cohort study with retrospective data collection, comparing patients infected by VOC Alpha to contemporaneous patients infected by historical lineages. Participants were matched on age (± 2.5 years), sex and region of hospitalization. The primary endpoint was the proportion of hospitalized participants with severe COVID-19, defined as a WHO-scale > 5 or by the need of a non-rebreather mask, occurring up to day 29 after admission. We used a logistic regression model stratified on each matched pair and accounting for factors known to be associated with the severity of the disease.
RESULTS RESULTS
We included 650 pairs of patients hospitalized between Jan 1, 2021, and Feb 28, 2021, in 47 hospitals. Median age was 70 years and 61.3% of participants were male. The proportion of participants with comorbidities was high in both groups (85.0% vs 90%, p = 0.004). Infection by VOC Alpha was associated with a higher odds of severe COVID-19 (41.7% vs 38.5%-aOR = 1.33 95% CI [1.03-1.72]).
CONCLUSION CONCLUSIONS
Infection by the VOC Alpha was associated with a higher odds of severe COVID-19.

Identifiants

pubmed: 35698029
doi: 10.1186/s12879-022-07508-x
pii: 10.1186/s12879-022-07508-x
pmc: PMC9189443
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

540

Investigateurs

Guillaume Martin-Blondel (G)
Pierre Delobel (P)
Gaspard Grouteau (G)
Jean Roch Le Henaff (JR)
Vincent Mear (V)
Sandra Lagarrigues (S)
Alais Frelat (A)
Thomas De Nadai (T)
Zara Steinmeyer (Z)
Arnaud Del Bello (A)
Stéphanie Ruiz (S)
Benjamine Sarton (B)
Elise Noel-Savina (E)
Jacques Izopet (J)
Nathan Peiffer-Smadja (N)
Michael Thy (M)
Mathilde Gare (M)
Diane Le Pluart (D)
François-Xavier Lescure (FX)
Christophe Rioux (C)
Laurène Deconinck (L)
Yazdan Yazdanpanah (Y)
None BenoitVisseaux
Diane Descamps (D)
Charlotte Charpentier (C)
Jean-Marc Chapplain (JM)
Pierre Tattevin (P)
Thomas Perpoint (T)
Maude Bouscambert-Duchamp (M)
Hodane Yonis (H)
Paul Chabert (P)
Hugues Cordel (H)
Youssouf Mohamed-Kassim (Y)
Nolan Hassold (N)
Segolène Brichler (S)
Julien Caliez (J)
Thomas Rambaud (T)
Marilucy Lopez-Sublet (M)
Frédéric Adnet (F)
Gilles Pialoux (G)
Christia Palacios (C)
Marwa Bachir (M)
Marine Nadal (M)
Mathieu Turpin (M)
Antoine Parrot (A)
Djeneba Fofana (D)
Jérome Pacanowski (J)
Karine Lacombe (K)
Emmanuelle Gras (E)
Laura Levi (L)
Laure Surgers (L)
Ines Devred (I)
Nadia Valin (N)
Thibault Chiarabini (T)
Jean Luc Meynard (JL)
Adeline Bauvois (A)
Clara Duran (C)
Elyanne Gault (E)
Jean-Emmanuel Kahn (JE)
Elisabeth Rouveix (E)
Guillaume Geri (G)
Didier Laureillard (D)
Albert Sotto (A)
Paul Loubet (P)
Claire Roger (C)
Julien Poissy (J)
Marc Lambert (M)
Ady Assaf (A)
Laurence Bocket (L)
Firouzé Bani-Sadr (F)
Yohan N'Guyen (Y)
Juliette Romaru (J)
Maxime Hentzien (M)
Thomas Gabas (T)
Amélie Chabrol (A)
Cecilia Billiou (C)
Philippe Menager (P)
Christophe Billy (C)
Jean-Jacques Laurichesse (JJ)
Fabrice Ketty N Simba (FKN)
Pauline Caraux Paz (PC)
Liliane Tinang (L)
Agathe Bounhiol (A)
Catherine Burnat (C)
Sandrine Soriot-Thomas (S)
Damien Basille (D)
Jean Philippe Lanoix (JP)
Yoan Zerbib (Y)
Yoann Zerbib (Y)
Anne Pouvaret (A)
Fanny Lanternier (F)
Helene Mascitti (H)
Aurélien Dinh (A)
Benjamin Davido (B)
Philippe Lesprit (P)
None Suresnes
None France
Service de Biologie Clinique Philippe Lesprit (S)
Eric Farfour (E)
Mathilde Neuville (M)
Linda Nait Allaoua (LN)
Michèle Lejaille (M)
Nathalie De Castro (N)
Jean-Michel Molina (JM)
Diane Ponscarme (D)
Mariagrazia Tateo (M)
Geoffroy Liegeon (G)
Ines Boussen (I)
Pauline Huriez (P)
André Cabié (A)
Valentine Campana (V)
Isabelle Calmont (I)
Jean-Marie Turmel (JM)
Guitteaud Karine (G)
Pierre-François Sandrine (PF)
Athéna Marquise (A)
Ornella Cabras (O)
Mélanie Lehoux (M)
Cyrille Chabartier (C)
Vincent Dubee (V)
Diama Ndiaye (D)
Caroline Lefeuvre (C)
Achille Kouatchet (A)
Duc Nguyen (D)
Camille Tumiotto (C)
Pierre Sioniac (P)
Alexandre Boyer (A)
Jean-François Faucher (JF)
Edouard Desvaux (E)
Sylvie Rogez (S)
Paul Le Turnier (P)
François Raffi (F)
Emmanuel Canet (E)
Antoine Roquilly (A)
Louise Castain (L)
Solène Secher (S)
Véronique Mondain (V)
Lionel Piroth (L)
Christelle Auvray (C)
Pascal Chavanet (P)
Marielle Buisson (M)
Sophie Mahy (S)
François-Xavier Catherine (FX)
Clementine Esteve (C)
Michel Duong (M)
Carole Charles (C)
Sandrine Gohier (S)
Céline Schaffer (C)
Olivier Robineau (O)
Perrine Bortolotti (P)
Maxime Pradier (M)
Francois Goehringer (F)
Alice Corbel (A)
Jeanne Kotzyba (J)
Kévin Alexandre (K)
Gaetan Beduneau (G)
Elodie Alessandri-Gradt (E)
Martin Martinot (M)
Simon Gravier (S)
Ciprian Ion (C)
Victoire de Lastours (V)
Roza Rahli (R)
Valérie Garrait (V)
Laurent Richier (L)
Mounira Smati-Lafarge (M)
Guillemette Frémont (G)
Pierre Louis Nivose (PL)
Marie Hélène André (MH)
Magdalena Gerin (M)
Aicha Hamdi (A)
Naomi Sayre (N)
Stephanie Cossec (S)
Sophie Alviset (S)
Pierre Alain Billy (PA)
Marie Gousseff (M)
Emmanuel Forestier (E)
Anne-Laure Destrem (AL)
Olivier Rogeaux (O)
Alexie Bosch (A)
Sabrina Bryant (S)
Gaëlle Bourgeois (G)
Ophélie Dos Santos Schaller (O)
Marie-Christine Carret (MC)
Nicolas Ettahar (N)
Haciba Moudjahed (H)
Nathalie Leone (N)
Mehdi Djennaoui (M)
Nicolas Lefebvre (N)
Axel Ursenbach (A)
François Danion (F)
Yvon Ruch (Y)
Morgane Solis (M)
Hamid Merdji (H)
Loïc Kassègne (L)
Fanny Pommeret (F)
Emeline Colomba Blameble (EC)
Merad Manssouria (M)
Annabelle Stoclin (A)
Franck Griscelli (F)
Sophie Deriaz (S)
Eric Oziol (E)
Laurent Favier (L)
Julien Obiols (J)
Pascal Gicquel (P)
Christophe Rapp (C)
Laurence Louvet (L)
Paul Ihout (P)
Jean-Benoit Zabbé (JB)
Laurent Bellec (L)
Tomasz Chroboczek (T)
Sandrine Mégessier (S)
Marie Lacoste (M)
Benjamin Viala (B)
Thibaut Challan-Belval (T)
Chloé Wackenheim (C)
Paule Letertre-Gibert (P)
Olivier Grossi (O)

Informations de copyright

© 2022. The Author(s).

Références

J Infect. 2021 Jul;83(1):119-145
pubmed: 33932451
Lancet Infect Dis. 2021 Nov;21(11):1518-1528
pubmed: 34171232
Euro Surveill. 2021 Mar;26(9):
pubmed: 33663644
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
N Engl J Med. 2021 May 13;384(19):1866-1868
pubmed: 33761203
BMJ. 2021 Jun 15;373:n1412
pubmed: 34130987
Nature. 2021 May;593(7858):270-274
pubmed: 33723411
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413740
Euro Surveill. 2021 Apr;26(16):
pubmed: 33890566
Lancet Infect Dis. 2021 Sep;21(9):1246-1256
pubmed: 33857406
J Travel Med. 2021 Feb 23;28(2):
pubmed: 33506254
Lancet Infect Dis. 2021 Aug;21(8):1070
pubmed: 34022142
Emerg Infect Dis. 2004 Sep;10(9):1550-7
pubmed: 15498155
Euro Surveill. 2021 Mar;26(11):
pubmed: 33739254
Lancet Public Health. 2021 May;6(5):e335-e345
pubmed: 33857453
Int J Infect Dis. 2021 Apr;105:753-755
pubmed: 33684558
Lancet Infect Dis. 2020 Aug;20(8):e192-e197
pubmed: 32539990

Auteurs

Guillaume Martin-Blondel (G)

Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. martin-blondel.g@chu-toulouse.fr.
Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), INSERM UMR1291, CNRS UMR5051, Université Toulouse III, Toulouse, France. martin-blondel.g@chu-toulouse.fr.

François-Xavier Lescure (FX)

Service des Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude-Bernard, APHP, Paris, France.

Lambert Assoumou (L)

Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.

Charlotte Charpentier (C)

Service de Virologie, Université de Paris, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, 75018, Paris, France.

Jean-Marc Chapplain (JM)

Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Rennes, Rennes, France.

Thomas Perpoint (T)

Service des Maladies Infectieuses et Tropicales, Hospices Civils de Lyon, Lyon, France.

Gaspard Grouteau (G)

Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.

Hugues Cordel (H)

Service des Maladies Infectieuses et Tropicales, Hôpital Avicenne, AP-HP, Bobigny, France.

Gilles Pialoux (G)

Service des Maladies Infectieuses et Tropicales, Hôpital Tenon, APHP, Paris, France.

Jérome Pacanowski (J)

Service des Maladies Infectieuses et Tropicales, Hôpital Saint-Antoine, APHP, Paris, France.

Michael Thy (M)

Service des Maladies Infectieuses et Tropicales, Hôpital Bichat-Claude-Bernard, APHP, Paris, France.

Adeline Bauvois (A)

Service de Médecine Interne, Hôpital Ambroise Paré, APHP, Boulogne-Billancourt, France.

Didier Laureillard (D)

Service des Maladies Infectieuses et Tropicales, Centre Hospitalier Universitaire de Nîmes, Nîmes, France.

Fadia Hamrouni (F)

Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.

Michèle Algarte-Genin (M)

Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.

Julien Poissy (J)

University of Lille, Inserm U1285, CHU Lille, Pôle de Médecine Intensive Réanimation, CNRS, UMR 8576, UGSF, Unité de Glycobiologie Structurale et Fonctionnelle, 59000, Lille, France.

Diane Descamps (D)

Service de Virologie, Université de Paris, INSERM, IAME, UMR 1137, AP-HP, Hôpital Bichat-Claude Bernard, 75018, Paris, France.

Dominique Costagliola (D)

Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (IPLESP), Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH